Investment Summary |
|
|---|---|
| Date | 2011-07-05 |
| Target | MyoPowers Medical Technologies SA |
| Sector | Medical Products |
| Investor(s) | Truffle Capital |
| Deal Type | Venture |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2001 |
| PE ASSETS | 700M EUR |
| Size | Middle-Market |
| Type | Sector Focused |
Truffle Capital is a French private equity firm focused on majority investments in life science and information technology companies. Within IT, Truffle seeks businesses dealing in mobile content and connectivity, internet, technical software, IT security, and VOIP. Within the life science sector, the Firm looks at opportunities in therapeutic drugs and vaccines, medical devices, as well as other breakthrough technologies. Truffle Capital was formed in 2001 and is based in Paris.
| DEAL STATS | # |
|---|---|
| Overall | 37 of 45 |
| Sector: Medical Products M&A | 5 of 7 |
| Type: Venture M&A Deals | 8 of 8 |
| Country: Switzerland M&A | 2 of 2 |
| Year: 2011 M&A | 2 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-06-27 |
Utel
Paris, France Utel is an editor of mobile services, especially audiotel and surcharged SMS. Utel was formed in 2000 and is based in Paris. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-10-04 |
RF-iT Solutions
Graz, Austria RFID is rapidly becoming a mainstream technology in the logistics, retail, manufacturing, pharmaceutical, garment rental, and asset tracking markets. |
Sell | - |
